On a recent CFIUS webcast, an expert in the venture capital industry provided insights and data that point to increased risks for biotech and life-science startups. Details, the full webcast, slide excerpts, and contact information are inside.
Subscribe For Complete Access
- Benefit from exclusive intelligence
- Download filings, CFIUS reviews, more
- Save hundreds of hours of research
- Track international regulatory regimes
You benefit from our independence
We are unbiased journalists. We don’t offer consulting or advisory services, so there’s no hidden message.
You save time and stay informed
Our updates help you track and understand the latest regulatory, ligitation, and enforcement developments.
You can download CFIUS disclosures
We track CFIUS disclosures, filings, updates, clearances, and more, all available in a downloadable Excel file.
You can use us to assist with research
We provide source documents and contacts to make your life easier, and are available to help with research.
If governments trust us, you should too
Whether a foreign investor, U.S. target, or legal counsel, you should read what the regulators read. That’s us.
“Foreign Investment Watch is a great resource on CFIUS!”
Damara Chambers, co-leader, Latham & Watkins’ CFIUS and U.S. National Security Practice
Anne Salladin, former Senior Counsel at the Treasury Department and CFIUS advisor